EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Modulation of cell fate by shock wave therapy in ischaemic heart disease

Michael Graber iD, Can Gollmann-Tepeköylü, Victor Schweiger, Jakob Hirsch iD, Leo Pölzl iD, Felix Nägele, Daniela Lener, Hubert Hackl iD, Sieghart Sopper iD, Elke Kirchmair, Sophia Mair, Jakob Voelkl und 11 weitere

European Heart Journal Open · 10.03.2025 · 5 (2)

DOI: 10.1093/ehjopen/oeaf011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 08.04.2025. Verfasst von Michael Graber und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac shockwave therapy (SWT) improves left ventricular (LV) function in patients with ischaemic cardiomyopathy. Shockwave therapy activates Toll-like receptor 3 (TLR3), a receptor-inducing chromatin remodelling and nuclear reprogramming of cardiac cells. We hypothesized that mechanical activation of TLR3 facilitates reprogramming of fibroblasts towards endothelial cells restoring myocardial perfusion and function. Methods and results Human cardiac fibroblasts were treated by mechanical stimulation via SWT or TLR3 agonist Poly(I:C) in the presence of endothelial induction medium. A lineage tracing experiment was performed in a transgenic mouse model of Fsp1-Cre/LacZ mice after coronary occlusion. Left ventricular function and scarring were assessed. Single-cell sequencing including RNA trajectory analysis was performed. Chromatin remodelling and epigenetic plasticity were evaluated via western blot and Assay for Transposase-Accessible Chromatin sequencing. Mechanical stimulation of human fibroblasts with SWT activated TLR3 signalling and enhanced the expression of endothelial genes in a TLR3-dependent fashion. The induced endothelial cells (ECs) resembled genuine ECs in that they produced endothelial nitric oxide and formed tube-like structures in Matrigel. In a lineage tracing experiment in Fsp1-Cre/LacZ mice, shockwave treatment increased LacZ/CD31-positive cells (indicating transdifferentiation) after coronary occlusion. Furthermore, SWT reduced myocardial scar size and improved LV function. Single-cell RNA-seq and RNA trajectory analyses revealed that SWT induced an endothelial fibroblast cluster and mechanical stimulation induced significant changes in chromatin organization, with chromatin being more accessible after both treatments in 1705 genomic regions.

Conclusion

Shockwave therapy enhances DNA accessibility via TLR3 activation and facilitates the transdifferentiation of fibroblasts towards endothelial cells in ischaemic myocardium.

Schlagwörter

Stichwörter der Autor:innen

Cardiac surgeryHeart regenerationShockwave therapyTherapeutic transdifferentiation

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, Innsbruck 6020, Austria.
  • Division of Clinical and Functional Anatomy, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Department of Internal Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Institute of Bioinformatics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Department of Hematology and Oncology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, Linz, Austria.

ORCID-Profile: Michael Graber, Jakob Hirsch, Leo Pölzl, Hubert Hackl, Sieghart Sopper, Ivan Tancevski, Johannes Holfeld

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Graber, M., Gollmann-Tepeköylü, C., Schweiger, V., Hirsch, J., Pölzl, L., Nägele, F., Lener, D., Hackl, H., Sopper, S., Kirchmair, E., Mair, S., Voelkl, J., Plattner, C., Eichin, F., Trajanoski, Z., Krogsdam, A., Eder, J., Fiegl, M., Hau, D., …, & Holfeld, J. (2025). Modulation of cell fate by shock wave therapy in ischaemic heart disease. European Heart Journal Open, 5(2). https://doi.org/10.1093/ehjopen/oeaf011

Vancouver

Graber M, Gollmann-Tepeköylü C, Schweiger V, Hirsch J, Pölzl L, Nägele F, et al. Modulation of cell fate by shock wave therapy in ischaemic heart disease. European Heart Journal Open. 2025;5(2). doi:10.1093/ehjopen/oeaf011

BibTeX
@article{Graber2025,
  author = {Graber, Michael and Gollmann-Tepeköylü, Can and Schweiger, Victor and Hirsch, Jakob and Pölzl, Leo and Nägele, Felix and Lener, Daniela and Hackl, Hubert and Sopper, Sieghart and Kirchmair, Elke and Mair, Sophia and Voelkl, Jakob and Plattner, Christina and Eichin, Felix and Trajanoski, Zlatko and Krogsdam, Anne and Eder, Jonas and Fiegl, Manuel and Hau, Dominik and Tancevski, Ivan and Grimm, Michael and Cooke, John P and Holfeld, Johannes},
  title = {Modulation of cell fate by shock wave therapy in ischaemic heart disease},
  journal = {European Heart Journal Open},
  year = {2025},
  volume = {5},
  number = {2},
  doi = {10.1093/ehjopen/oeaf011}
}
Kostenlos starten →